Subgroup classification of receptor tyrosine kinase (RTK) pathway activation in KRAS-mutated metastatic carcinoma

被引：0
|
作者：
Wang, Y. [1 ]
Windham, J. P. [1 ]
Samul, R. A. [1 ]
Sanidad, M. A. [1 ]
Farooqui, A. [1 ]
Gorman, B. M. [1 ]
Kelly, J. C. [1 ]
Meloni-Ehrig, A. M. [1 ]
Jones, D. [1 ]
机构：
[1] Quest Diagnost Nichols Inst, Chantilly, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18019
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer
    Stebbing, Justin
    Bullock, Andrea J.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2005 - 2007
  • [2] Receptor tyrosine kinase dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated colorectal cancer cell lines
    Vitiello, P. P.
    Cardone, C.
    Ciardiello, D.
    Barra, G.
    Matrone, N.
    Belli, V.
    Martini, G.
    Poliero, L.
    Borrelli, C.
    Terminiello, M.
    Troiani, T.
    Morgillo, F.
    Ciardiello, F.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
    Pietro Paolo Vitiello
    Claudia Cardone
    Giulia Martini
    Davide Ciardiello
    Valentina Belli
    Nunzia Matrone
    Giusi Barra
    Stefania Napolitano
    Carmina Della Corte
    Mimmo Turano
    Maria Furia
    Teresa Troiani
    Floriana Morgillo
    Ferdinando De Vita
    Fortunato Ciardiello
    Erika Martinelli
    Journal of Experimental & Clinical Cancer Research, 38
  • [4] Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
    Vitiello, Pietro Paolo
    Cardone, Claudia
    Martini, Giulia
    Ciardiello, Davide
    Belli, Valentina
    Matrone, Nunzia
    Barra, Giusi
    Napolitano, Stefania
    Della Corte, Carmina
    Turano, Mimmo
    Furia, Maria
    Troiani, Teresa
    Morgillo, Floriana
    De Vita, Ferdinando
    Ciardiello, Fortunato
    Martinelli, Erika
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [5] Receptor Tyrosine Kinase Pathway and Infiltrating Urothelial Carcinoma
    Buyucek, Seyma
    Coskun, Sinem K.
    Onal, Binnur
    Gamsizkan, Mehmet
    Cangur, Sengul
    Esbah, Onur
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2023, 42 (01) : 65 - 77
  • [6] Visualization of the Receptor Tyrosine kinase (RTK)/Ras/mitogen activated protein (MAP) kinase signaling pathway
    Matsuda, Michiyuki
    Terai, Kenta
    CANCER SCIENCE, 2021, 112 : 130 - 130
  • [7] Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
    Miao, H
    Wei, BR
    Peehl, DM
    Li, Q
    Alexandrou, T
    Schelling, JR
    Rhim, JS
    Sedor, JR
    Burnett, E
    Wang, BC
    NATURE CELL BIOLOGY, 2001, 3 (05) : 527 - 530
  • [8] Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
    Hui Miao
    Bih-Rong Wei
    Donna M. Peehl
    Qing Li
    Terry Alexandrou
    Jeffrey R. Schelling
    Johng S. Rhim
    John R. Sedor
    Elisabeth Burnett
    Bingcheng Wang
    Nature Cell Biology, 2001, 3 : 527 - 530
  • [9] Mechanism for acute activation of eNOS by statins involves PLC and receptor tyrosine kinase (RTK) pathways
    Datar, R
    Kaesemeyer, WH
    Harris, BM
    Fulton, DJ
    Caldwell, RW
    FASEB JOURNAL, 2004, 18 (04): : A233 - A233
  • [10] MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
    Fanini, Francesca
    Bandini, Erika
    Plousiou, Meropi
    Carloni, Silvia
    Wise, Petra
    Neviani, Paolo
    Murtadha, Mariam
    Foca, Flavia
    Fabbri, Francesco
    Vannini, Ivan
    Fabbri, Muller
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
12345